The molecular, biochemical and human pharmacology of thromboxane A2 in renal disease.
FitzGerald
G A
GA
Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee 37232.
Murray
R
R
Price
P
P
Catella
F
F
D016861:Cyclooxygenase Inhibitors; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism*; D013928:Thromboxane A2 / Q000096:biosynthesis / Q000378:metabolism* / Q000494:pharmacology
D016861:Cyclooxygenase Inhibitors; D013928:Thromboxane A2